Page 14 - NIS English February1-15

Cover Story War Against Corona

Indigenous vaccine will be economical and effective INDIA WORKING ON
Producer Price Temperature FOUR MORE VACCINES
Covishield (India) 200 2-8 Degree
Covaxin (India) 206 2-8 Degree l Zydus Cadilla:
Pfizer (being used in many countries) 1431 -70 Degree The Ahmedabad-based
Modarna 2700 2-8 Degree company has concluded its
Sinopharm (China) 5650 2-8 Degree Phase 2 trials in December
Cyanowek Biotech (China) 1027 2-8 Degree 2020. Now, its Phase 3 trials

Novavax 1114 2-8 Degree are underway
Sputnik-V (Russia's Gamalia Center) 734* 2-8 Degree l Sputnik V:
Johnson & Johnson 734 2-8 Degree The DCGI has approved the
Phase 3 clinical trials of
Price- In Rs, * When it will be produced in India, then the price here is different.
Sputnik V vaccine, made by
Russia‘s Gamaleya Research
INDIA LEADING THE WORLD IN FIGHT AGAINST Institute of Epidemiology
CORONAVIRUS: TAKING RIGHT STEPS and Microbiology.
Hyderabad-based Dr.
When the Prime Minister announced lockdown on March 24,
n Reddy‘s Laboratories are
2020, India was having about 500 Coronavirus cases conducting the trials in India
When the lockdown was announced, the infection count was l Biological E:
n
doubling in just three days and the cases were increasing at a Based in Hyderabad, it is
speed of 19.6 per cent developing a protein-based
It would have been of no use had there been any delay in vaccine. The BE vaccine
n
implementing the lockdown. That was the tipping point when is being developed in
the wave of infection could have affected a large section of the collaboration with the Baylor
population College of Medicine, US, and

n That was a challenging phase for the Government. It was also is under Phase 1 trial. Its
a crucial time to build infrastructure to fight the pandemic Phase 2 is likely to start from
March 2021
The lockdown period was used to develop the health
n lGennova:
infrastructure for fighting Coronavirus pandemic. For COVID-19 Pune-based Gennova
treatment, 15,362 health facilities, about 15.40 Lakh isolation
beds, 2.70 Lakh Oxygen support beds and 78,000 ICU beds Biopharmaceuticals has
were prepared also entered the human
trial stage. It is an mRNA
n 32,400 ventilators were delivered to Government hospitals. COVID-19 vaccine. Phase
These hospitals had only 12,000 ventilators 1 trial is underway while the
The State Governments were given 3.70 Crore N-95 masks and second phase trial can be
n
1.60 Crore PPE kits done by May 2021

In comparison to other vaccines, India’s vaccine India has launched its last strike on Corona,
is effective and economical. Head of the Expert using the 5 key principles of the Prime Minister—
Group, Dr V.K. Paul said, “This is a very safe ensuring people’s participation, use of booth
vaccine with almost no side effects. There is no level work in elections and experiences of
possibility of any risk; there may be a little fatigue public immunisation programme, existing health
or pain after getting vaccinated. But we have to services are not affected, adherence to scientific
make sure that we accept the vaccine, and save and regulatory norms and running an IT-based
ourselves and the country.” campaign.

12 New India Samachar